Detailed information for compound 603386

Basic information

Technical information
  • TDR Targets ID: 603386
  • Name: (E)-3-(2,3-difluorophenyl)prop-2-enoic acid
  • MW: 184.14 | Formula: C9H6F2O2
  • H donors: 1 H acceptors: 2 LogP: 2.07 Rotable bonds: 2
    Rule of 5 violations (Lipinski): 1
  • SMILES: OC(=O)/C=C/c1cccc(c1F)F
  • InChi: 1S/C9H6F2O2/c10-7-3-1-2-6(9(7)11)4-5-8(12)13/h1-5H,(H,12,13)/b5-4+
  • InChiKey: NVQHKPLMLCHFSU-SNAWJCMRSA-N  


Substructure search Similarity search

Network

Hover on a compound node to display the structore

Synonyms

  • 3-(2,3-difluorophenyl)prop-2-enoic acid
  • 3-(2,3-difluorophenyl)acrylic acid
  • (E)-3-(2,3-difluorophenyl)acrylic acid
  • JRD-0446
  • 2,3-Difluorocinnamic acid

Targets

Known targets for this compound

No curated genes were found associated with this compound

Predicted pathogen targets for this compound

By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity
Obtained from network model

Ranking Plot

Putative Targets List

Species Potential target Raw Global Species
Schistosoma mansoni hypothetical protein 0.0016 0.2052 0.1968
Brugia malayi Corticotropin releasing factor receptor 2 precursor, putative 0.0052 0.7745 0.7527
Brugia malayi TAR-binding protein 0.0066 1 1
Schistosoma mansoni hypothetical protein 0.0016 0.2052 0.1968
Trichomonas vaginalis chromodomain-helicase-DNA-binding protein, putative 0.0007 0.0504 1
Echinococcus multilocularis GPCR, family 2 0.0016 0.2052 0.1537
Trichomonas vaginalis conserved hypothetical protein 0.0007 0.0504 1
Loa Loa (eye worm) RNA recognition domain-containing protein domain-containing protein 0.0066 1 1
Loa Loa (eye worm) CXXC zinc finger family protein 0.003 0.4215 0.3642
Brugia malayi RNA recognition motif domain containing protein 0.0066 1 1
Echinococcus granulosus tar DNA binding protein 0.0066 1 1
Schistosoma mansoni cpg binding protein 0.003 0.4215 0.4154
Schistosoma mansoni hypothetical protein 0.0016 0.2052 0.1968
Schistosoma mansoni tar DNA-binding protein 0.0066 1 1
Echinococcus granulosus diuretic hormone 44 receptor GPRdih2 0.0016 0.2052 0.1537
Trichomonas vaginalis conserved hypothetical protein 0.0007 0.0504 1
Schistosoma mansoni mixed-lineage leukemia protein mll 0.0007 0.0609 0.0509
Brugia malayi calcium-independent alpha-latrotoxin receptor 2, putative 0.0016 0.2052 0.1283
Echinococcus multilocularis histone lysine N methyltransferase MLL3 0.0009 0.0901 0.0311
Brugia malayi Calcitonin receptor-like protein seb-1 0.0052 0.7745 0.7527
Trichomonas vaginalis conserved hypothetical protein 0.0007 0.0504 1
Trichomonas vaginalis conserved hypothetical protein 0.0007 0.0504 1
Onchocerca volvulus 0.003 0.4215 0.5
Echinococcus multilocularis diuretic hormone 44 receptor GPRdih2 0.0016 0.2052 0.1537
Schistosoma mansoni tar DNA-binding protein 0.0066 1 1
Trichomonas vaginalis chromodomain helicase DNA binding protein, putative 0.0007 0.0504 1
Trichomonas vaginalis chromodomain helicase DNA binding protein, putative 0.0007 0.0504 1
Loa Loa (eye worm) TAR-binding protein 0.0066 1 1
Schistosoma mansoni tar DNA-binding protein 0.0066 1 1
Schistosoma mansoni cpg binding protein 0.0032 0.4488 0.443
Trichomonas vaginalis conserved hypothetical protein 0.0007 0.0504 1
Echinococcus multilocularis cadherin EGF LAG seven pass G type receptor 0.0016 0.2052 0.1537
Toxoplasma gondii histone lysine methyltransferase SET1 0.0057 0.8507 0.5
Trichomonas vaginalis chromodomain helicase DNA binding protein, putative 0.0007 0.0504 1
Trichomonas vaginalis conserved hypothetical protein 0.0007 0.0504 1
Brugia malayi CXXC zinc finger family protein 0.003 0.4215 0.3655
Schistosoma mansoni mixed-lineage leukemia protein mll 0.0064 0.9594 0.959
Echinococcus granulosus cadherin EGF LAG seven pass G type receptor 0.0016 0.2052 0.1537
Trichomonas vaginalis conserved hypothetical protein 0.0007 0.0504 1
Trichomonas vaginalis chromodomain helicase DNA binding protein, putative 0.0007 0.0504 1
Loa Loa (eye worm) hypothetical protein 0.0016 0.2052 0.1265
Loa Loa (eye worm) latrophilin receptor protein 2 0.0016 0.2052 0.1265
Echinococcus multilocularis tar DNA binding protein 0.0066 1 1
Brugia malayi latrophilin 2 splice variant baaae 0.0036 0.511 0.4637
Schistosoma mansoni tar DNA-binding protein 0.0066 1 1
Schistosoma mansoni cpg binding protein 0.0032 0.4488 0.443
Echinococcus granulosus cpg binding protein 0.0032 0.4488 0.4131
Trichomonas vaginalis chromodomain-helicase-DNA-binding protein, putative 0.0007 0.0504 1
Trichomonas vaginalis chromodomain helicase DNA binding protein, putative 0.0007 0.0504 1
Trichomonas vaginalis helicase, putative 0.0007 0.0504 1
Brugia malayi Latrophilin receptor protein 2 0.0016 0.2052 0.1283
Schistosoma mansoni tar DNA-binding protein 0.0066 1 1
Trichomonas vaginalis conserved hypothetical protein 0.0007 0.0504 1
Loa Loa (eye worm) hypothetical protein 0.0052 0.7745 0.7522
Echinococcus granulosus histone lysine N methyltransferase MLL3 0.0009 0.0901 0.0311
Schistosoma mansoni hypothetical protein 0.0036 0.511 0.5058
Echinococcus multilocularis cpg binding protein 0.0032 0.4488 0.4131
Trichomonas vaginalis chromodomain helicase DNA binding protein, putative 0.0007 0.0504 1
Schistosoma mansoni hypothetical protein 0.0016 0.2052 0.1968
Loa Loa (eye worm) hypothetical protein 0.0036 0.511 0.4626
Loa Loa (eye worm) RNA binding protein 0.0066 1 1
Echinococcus granulosus GPCR family 2 0.0016 0.2052 0.1537
Trichomonas vaginalis conserved hypothetical protein 0.0007 0.0504 1
Loa Loa (eye worm) pigment dispersing factor receptor c 0.0052 0.7745 0.7522

Activities

Activity type Activity value Assay description Source Reference
Inhibition (functional) = 0 % GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 LDH activity, using an LDH reporter assay. Test compounds present at 2uM ChEMBL. 20485427
Inhibition (functional) = 1 % GSK_TCMDC: Inhibition of Plasmodium falciparum Dd2 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM ChEMBL. 20485427
Inhibition (functional) = 1.29 % ST_JUDE_LEISH: Cytotoxicity at 2uM final concentration against transgenic Leishmania Mexicana promastigotes LmGLUT1 that are glucose transport deficient and complemented with the human glucose transporter GLUT1. Activity is measured by DNA content using SYBR green in vitro ChEMBL. No reference
Inhibition (functional) = 1.5 % ST_JUDE_LEISH: Cytotoxicity at 2uM final concentration against transgenic Leishmania Mexicana promastigotes LmPfHT that are glucose transport deficient and complemented with the Plasmodium falciparum hexose transporter. Activity is measured by by DNA content using SYBR green in vitro ChEMBL. No reference
Inhibition (functional) = 2.66 % ST_JUDE_LEISH: Cytotoxicity at 2uM final concentration against transgenic Leishmania Mexicana promastigotes LmGT2 that are glucose transport deficient and complemented with the L. Mexicana glucose transporter 2. Activity is measured by by DNA content using SYBR green in vitro ChEMBL. No reference
Inhibition (functional) = 58 % GSK_TCMDC: Percent inhibition of human HepG2 cell line. Test compounds present at 10uM. ChEMBL. 20485427
Inhibition (functional) = 96 % GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM ChEMBL. 20485427
Inhibition frequency index (IFI) (functional) = 2.16 Inhibition Frequency Index (IFI) GSK. 20485427
Percent growth inhibition (functional) = -1 % Percent inhibition of P. falciparum lactate dehydrogenase activity (at 2 uM) GSK. 20485427
Percent growth inhibition (functional) = 1 % Percent inhibition of P. falciparum Dd2 growth (at 2 uM) GSK. 20485427
Percent growth inhibition (functional) = 58 % Percent inhibition of HepG2 growth (at 10 uM) GSK. 20485427
Percent growth inhibition (functional) = 96 % Percent inhibition of P. falciparum 3D7 growth (at 2 uM) GSK. 20485427
XC50 (functional) = 7.02 XC50 determination of P. falciparum 3D7 growth GSK. 20485427
XC50 (functional) = 0.09606 uM GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole erythrocytes, using parasite LDH activity as an index of growth. ChEMBL. 20485427

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

1 literature reference was collected for this gene.

If you have references for this compound, please enter them in a user comment (below) or Contact us.